FDA Drug Application (020505) for TOPAMAX by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number020505
Product Number001
FormTABLET;ORAL
Dosage100MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTOPAMAX
Active IngredientTOPIRAMATE

Active IngredientCount
List of drugs with Active Ingredient TOPIRAMATE6


Back to FDA Applications sponsored by JANSSEN PHARMS